Back
Sagimet Biosciences Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
65
SGMT
Sagimet Biosciences
Last Price:
4.88
Seasonality Move:
64.91%
Buy
54
MDGL
Madrigal Pharmaceuticals
Last Price:
312.98
Seasonality Move:
22.96%
Buy
65
Sagimet Biosciences (SGMT)
is a Buy
Is Sagimet Biosciences a Buy, Sell or Hold?
- The current Sagimet Biosciences [SGMT] share price is $4.89. The Score for SGMT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- SGMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $312.77. The Score for MDGL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SGMT Stock Price Chart
What is Sagimet Biosciences's stock price today?
-
The Sagimet Biosciences share price today is $4.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SGMT is experiencing slight selling pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $312.77
The current trend is moderately bearish and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
SGMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 46.51 | Sell |
| Chaikin Money Flow: | -137186 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.69 - 5.81) | Sell |
| Bollinger Bands (100): | (2.91 - 5.23) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.55 | Buy |
| Relative Strength Index (14 RSI): | 51.82 | Buy |
| Chaikin Money Flow: | -166612 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (309.7 - 341.76) | Sell |
| Bollinger Bands (100): | (217.6 - 306.88) | Buy |
SGMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.16 | Sell |
| 20-day SMA: | 5.07 | Sell |
| 50-day SMA: | 5.09 | Sell |
| 200-day SMA: | 4.33 | Buy |
| 8-day EMA: | 5.05 | Sell |
| 20-day EMA: | 5.12 | Sell |
| 50-day EMA: | 4.89 | Sell |
| 200-day EMA: | 5.03 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 318.96 | Sell |
| 20-day SMA: | 321.11 | Sell |
| 50-day SMA: | 274.16 | Buy |
| 200-day SMA: | 254.91 | Buy |
| 8-day EMA: | 319.09 | Sell |
| 20-day EMA: | 315.51 | Sell |
| 50-day EMA: | 291.07 | Buy |
| 200-day EMA: | 255.34 | Buy |
Sagimet Biosciences Earnings Growth & SGMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.78 per share, and a decrease next year of $1.96 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.12 per share, and an increase next year of $10.27 per share.
Sagimet Biosciences Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||